Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02264977 · ClinicalTrials.gov registry record · NA
Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms
A NA study of Aneurysm of Aortic Arch, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 6
- Study locations
NCT02264977: Completed NA study of Aneurysm of Aortic Arch, sponsored by W.L.Gore & Associates.
NCT02264977 is a NA study of Aneurysm of Aortic Arch that has completed, run by W.L.Gore & Associates. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02264977, a NA study of Aneurysm of Aortic Arch, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess the early feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the aortic arch
Primary Outcome
Access to the aneurysm and target landing zone location is obtained via conventional vascular access and endovascular techniques.
Conditions Studied
Interventions
- DEVICE GORE® TAG® Thoracic Branch Endoprosthesis
Study Locations (6)
Pennsylvania
- Hospital at University of Pennsylvania - Philadelphia
- Univerisity of Pittsburgh Medical Center - Pittsburgh
California
- Leland Stanford Junior University - Stanford
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic Rochester - Rochester
New Hampshire
- The Hitchcock Foundation (Dartmouth Hitchcock Medical Center) - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-04 |
| Est. Completion | 2022-03 |
| Phase | NA |
What the finished NCT02264977 record still lists
NCT02264977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Aneurysm of Aortic Arch appearing as the primary indexed condition, and to 1 intervention - of which GORE® TAG® Thoracic Branch Endoprosthesis is the first listed.
NCT02264977 lists 6 locations in 5 states (Pennsylvania, California, Michigan).
Frequently Asked Questions
What is clinical trial NCT02264977 about?
NCT02264977 is a clinical study titled "Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms". The purpose of this study is to assess the early feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the aortic arch
What is the current status of trial NCT02264977?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-04. Estimated completion is 2022-03.
What conditions does trial NCT02264977 study?
This clinical trial studies the following conditions: Aneurysm of Aortic Arch.
What interventions are being tested in trial NCT02264977?
The interventions under investigation include: GORE® TAG® Thoracic Branch Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT02264977?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02264977 being conducted?
This trial has 6 study locations across California, Michigan, Minnesota, New Hampshire, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02264977's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia